Lawsuit Information Center
A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device does not just fail to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.
This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.
Many people arrive here with a practical question in mind: what do spinal cord stimulator settlement amounts look like, and how does compensation get calculated when a device causes lasting harm? That question cannot be answered in isolation. Settlement amounts and payouts are driven by the full medical timeline, including the cost of repeat surgeries, explantation, permanent loss of function, and the downstream consequences when a pain-management device leaves someone worse off than before it was implanted.
What follows is a detailed breakdown of the allegations, the regulatory history behind these devices, the types of injuries being reported, and how spinal cord stimulator compensation is evaluated in serious cases.
If you or a loved one suffered complications after implantation, this page is meant to help you understand not just whether you may have a claim, but why these cases are being taken seriously across the country.
Get a free no-obligation consultation or call us today at 800-553-8082.
Spinal Cord Stimulator Lawsuit Updates
February 27, 2026 – Spinal Cord Stimulator Lawsuit Dismissed
A Michigan federal judge on Tuesday tossed a WaveWriter spinal cord stimulator case against Boston Scientific, finding the claims preempted under the FDCA and the Medical Device Amendments because the device went through FDA Premarket Approval.
The plaintiff alleged the implant stopped working as intended, produced painful, shocking sensations after revisions, could not be successfully reprogrammed, and ultimately had to be removed, leaving lasting nerve symptoms. He sued on failure to warn and manufacturing defect theories, arguing the company should have responded to post-market safety signals and that the device was not made in compliance with the federally approved specifications.
The court held that the warning theory would require different or additional warnings beyond FDA-approved labeling and that the manufacturing and negligence theories were not tied to a specific parallel Michigan duty, so the case was dismissed with prejudice.
Preemption is the defense argument that federal device regulation overrides state tort claims for PMA Class III devices unless a plaintiff fits through a narrow gap: a traditional state law claim that mirrors a concrete federal requirement. The problem is that this approach often demands granular quality system facts at the pleading stage that plaintiffs typically cannot access without discovery, effectively turning the manufacturer’s control of information into a shield.
If higher courts adopt this reasoning broadly, it will shrink these spinal stimulator cases to a small subset of tightly pleaded manufacturing deviation claims and weaken leverage across the litigation.
We do not think preemption will apply as a blanket bar here because PMA approval is not a lifetime immunity deal, and companies still have to follow the rules and respond to what they learn after the device is on the market.
February 19, 2026 – Spinal Cord Stimulator MDL Sought
A group of plaintiffs has asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits involving Abbott and Boston Scientific spinal cord stimulators into an MDL in the Northern District of Illinois.
The motion, filed under 28 U.S.C. § 1407, seeks to centralize at least fifteen pending cases across five jurisdictions, most of which also name the FDA under the Administrative Procedure Act.
Plaintiffs argue that the cases share core factual and legal questions involving device design, federal regulatory compliance, and preemption defenses, and that consolidation would prevent inconsistent rulings and duplicative discovery. No court has yet ruled on key motions, including federal preemption defenses that are already fully briefed in at least one case.
The lawsuits allege that Abbott’s spinal cord stimulator line traces back to the Genesis system approved in 2001 under PMA P010032, and Boston Scientific’s line to the Precision system approved in 2004 under PMA P030017. Plaintiffs contend that neither original approval was supported by independent clinical trial data specific to the devices. Instead, the FDA allegedly relied on published literature involving other manufacturers’ systems.
Since then, both companies have introduced successive generations of stimulators through PMA supplements rather than new PMA applications, despite incorporating substantial changes such as multiwaveform stimulation modes, posture-adaptive programming, expanded electrode arrays, Bluetooth-enabled interfaces, revised battery architecture, and redesigned leads. Plaintiffs argue these modifications fundamentally altered the devices’ safety profiles while avoiding the more rigorous scrutiny required for new Class III approvals.
This is a big problem. The FDA received a stunning 107,728 adverse event reports related to spinal cord stimulators over a four-year period, including more than 30,000 complaints of unsatisfactory pain relief. Plaintiffs allege that the agency failed to meaningfully review supplemental approvals and unlawfully permitted manufacturers to bring materially different devices to market through a regulatory shortcut.
Every spinal cord stimulator lawsuit asserts injuries, including lead migration, electrical shocks, burning sensations, neurological injury, autonomic dysfunction, and chronic pain exacerbation. With roughly 50,000 spinal cord stimulators implanted annually and the two companies controlling a majority market share, plaintiffs argue that tens of thousands of additional claims may exist. They contend that consolidating the cases in Illinois, where Abbott is headquartered and multiple actions are already pending, would promote judicial economy and ensure consistent rulings on preemption and regulatory oversight issues.
February 2, 2026 – New Spinal Cord Stimulator Lawsuit
A new spinal cord stimulator lawsuit was filed alleging that a Boston Scientific spinal cord stimulator battery malfunctioned and required surgical removal after the device failed and caused worsening pain and complications. This adds to litigation over implanted neuromodulation devices that plaintiffs say did not perform as represented and led to additional procedures.
October 17, 2026 – Spinal Cord Lawsuit in California
A federal lawsuit was filed in the Central District of California against Boston Scientific and the FDA over the Spectra WaveWriter device. The complaint alleges that lead migration and subsequent complications, including cardiac arrhythmia, resulted from substantial device modifications that improperly used the FDA’s PMA supplement pathway instead of requiring a full PMA review. The plaintiff is seeking damages and a jury trial.
Spinal Cord Stimulators
Spinal cord stimulation devices are Class III implantable neuromodulation systems intended to deliver controlled electrical impulses to the spinal cord to manage chronic, intractable pain. These systems generally include an implantable pulse generator, one or more electrical leads placed near the spinal cord, and an external controller that allows the patient to adjust stimulation levels.
The theory behind spinal cord stimulation is that targeted electrical impulses applied to the dorsal columns of the spinal cord can interfere with or alter the transmission of pain signals before they reach the brain. By modulating these signals, the devices are intended to provide relief for patients whose pain has not responded to more conventional treatment options.
Despite their intended benefits, spinal cord stimulation systems carry significant and well-documented risks. Reported complications include device migration, lead fracture or displacement, battery malfunction, infection, neurological injury related to stimulation, worsening pain, and autonomic dysfunction.
Because of these substantial risks, the FDA classifies spinal cord stimulation systems as Class III medical devices. This designation requires rigorous Premarket Approval and supplemental review for any design or functional modifications that could affect the device’s safety or effectivenes
Spinal Cord Stimulator Lawsuits: Allegations of Defective Medical Devices
Across the United States, patients are filing lawsuits involving spinal cord stimulators (SCS), alleging these implantable pain-management devices were defectively designed and unreasonably dangerous. According to FDA adverse-event data, thousands of complaints have been reported involving spinal cord stimulators, including burns, infections, device migration, electrical malfunction, and the need for repeated corrective surgeries.
Major manufacturers—including Boston Scientific, Medtronic, Abbott, and Nevro Corp—are accused of failing to adequately warn patients and physicians about known risks associated with these devices. Independent scientific studies have raised concerns that spinal cord stimulators are prone to lead migration, hardware failure, and electrical defects, which can result in serious neurological injury and long-term complications.
Many patients report they were never fully informed of these dangers before implantation. After suffering burns, infections, worsening pain, paralysis, or undergoing revision surgeries or complete device removal, patients often face significant physical pain, emotional distress, and financial hardship. As a result, injured individuals and their families are pursuing spinal cord stimulator lawsuits to seek compensation and accountability.
What separates spinal cord stimulator lawsuits from ordinary medical malpractice cases is not just the severity of the injuries, but the regulatory and design history behind these devices. Many of the most serious claims now being filed do not focus solely on surgical error or isolated malfunction. Instead, they examine how modern spinal cord stimulators were approved, how dramatically they changed over time, and whether patients were ever protected by the safety testing they were led to believe occurred.
Reported Spinal Cord Stimulator Complications
Spinal cord stimulator injuries being alleged in lawsuits include:
Common Alleged Injuries and Complications
- ●Lead migration requiring revision surgery
- ●Electrical malfunction causing shocks or burns
- ●Device overheating
- ●Hardware failure
- ●Infection
- ●Scar tissue complications
- ●Worsening neuropathic pain
- ●Paralysis or weakness
- ●Autonomic dysfunction
- ●Bowel or bladder loss
- ●Cardiac complications
- ●Death following postoperative complications
One reported case involved an elderly patient, whom we talk about below, who developed Ogilvie syndrome following implantation. The complication progressed to bowel rupture and multi-organ failure. While causation remains disputed, similar autonomic complications have been reported following neuromodulation procedures.
Another lawsuit alleges a WaveWriter Alpha stimulator migrated and delivered painful shocks, with company representatives allegedly adjusting the device without a physician present.
These fact patterns are not identical. But the themes are consistent: device movement, electrical malfunction, worsening symptoms, and inadequate warning.
How FDA Approval Is Being Used As A Shield
One of the first things spinal cord stimulator manufacturers point to when patients are injured is FDA approval. The implication is simple and powerful: the device was approved, therefore it must be safe. But that framing omits how spinal cord stimulators reached the market and how they have evolved over time.
Spinal cord stimulators are classified as Class III medical devices, the highest risk category under federal law. So in theory, that classification means the device must undergo rigorous premarket approval, including clinical testing, before it can be sold. This is as it should be, right? In practice, many of today’s spinal cord stimulators trace their approval back to much older devices, approved decades ago, through a regulatory pathway that allows manufacturers to make changes without submitting new clinical evidence each time.
Manufacturers are permitted to update devices through PMA supplements. These are intended to cover limited, incremental changes that do not meaningfully alter how a device works or how risky it is. The problem arises when companies rely on this process to roll out sweeping design changes over many years without ever returning to the FDA for a full review.
In the spinal cord stimulator space, manufacturers have introduced major modifications to battery systems, lead designs, stimulation waveforms, wireless communication features, posture-adaptive algorithms, and multi-source current delivery. These are not cosmetic tweaks. They directly affect how electrical signals are delivered to the spinal cord and how the device behaves inside the body.
Yet many of these changes were cleared through paperwork rather than new human trials. As a result, patients may be implanted with devices that are materially different from the versions originally approved, even though the FDA approval label remains the same. From the patient’s perspective, the device appears fully vetted. From a regulatory standpoint, the safety data often lags far behind the technology.
This regulatory gap matters in real-world terms. When a device malfunctions, migrates, overheats, or delivers unintended electrical shocks, manufacturers often argue that these outcomes fall within “known risks.” But a risk cannot be meaningfully known if the device has evolved beyond the version that was ever properly studied.
Lawsuits now being filed across the country allege that manufacturers exploited this regulatory structure by stacking change upon change without conducting the testing needed to reveal long-term failure rates or rare but devastating complications. Plaintiffs also allege that warnings never reflected how these newer systems behaved once implanted in patients.
The result is a familiar pattern in modern medical device litigation. FDA approval becomes a talking point, not a safeguard. Devices reach patients faster than the science can keep up, and serious complications are only fully recognized after thousands of people have already been exposed.
This is why many spinal cord stimulator lawsuits focus not just on individual injuries but also on whether manufacturers complied with the spirit and intent of the regulatory system. The core allegation is not that innovation is bad. It is that innovation without accountability shifts the risk onto patients who never agreed to be test subjects.
Elderly Patient Dies After Colon Complication Following SCS Implant
In mid-December, an elderly man received a spinal cord stimulator to treat chronic pain. Shortly after implantation, he developed Ogilvie’s syndrome. This complication in elderly or medically fragile patients after surgery or neurologic interference. It has been reported in connection with spinal procedures and neuromodulation, including SCS implantation, particularly when autonomic nerve function is affected.
The swelling in this patient, unfortunately, became so severe that it ruptured his cecum, triggered multiple organ failure, and ultimately led to his death. The condition is believed to be linked to complications from the spinal cord stimulator. Similar reports involving electrocution, infections, and device migration have prompted patients and families nationwide to pursue legal claims against device manufacturers.
Virginia Woman Sues FDA and Boston Scientific Over Defective Device
A Virginia woman has filed a spinal cord simulator lawsuit against Boston Scientific and the U.S. Food and Drug Administration, alleging that a defective spinal cord stimulator caused severe and worsening injuries after implantation.
According to the complaint, the woman received a WaveWriter Alpha spinal cord stimulator to manage chronic pain, but instead, it made things worse, and she experienced electrical shocks, device migration, and escalating physical harm.
The lawsuit further alleges that the device moved from its intended position and delivered painful electrical impulses that were not only ineffective but also dangerous. Doctors sometimes call this migration, and it can cause real damage to the patient in many different contexts
The patient also claims that company representatives adjusted and altered the device without her physician present, dismissing her concerns even as her condition deteriorated. If you are following this medical device, you would not be surprised, as the allegations mirror reports documented in FDA adverse-event data, in which other patients have described similar injuries linked to the same device system.
In addition to claims against the manufacturer, the lawsuit raises serious questions about regulatory oversight. The plaintiff alleges that Boston Scientific continued to market and sell a spinal cord stimulator that materially differed from the version originally approved by the FDA, without undergoing proper supplemental review or safety testing. The complaint asserts that these changes increased the risk of injury while depriving patients and physicians of critical information needed to make informed decisions.
The case highlights a growing concern in spinal cord stimulator litigation: that device manufacturers may prioritize speed to market and continued sales over patient safety, while regulators fail to intervene despite mounting evidence of harm. Although the case remains pending, it reflects broader allegations being raised nationwide by patients who say they were never adequately warned about the risks associated with these devices—and who now face lasting pain, repeated procedures, and diminished quality of life.
Patient Alleges FDA Wrongfully Approved Defective Stimulator
A woman filed suit against Boston Scientific and the FDA after her Spectra WaveWriter spinal cord stimulator migrated, causing severe pain and heart complications. The plaintiff claims the manufacturer failed to disclose known defects and that the FDA improperly allowed continued production of a significantly altered device without requiring new safety approvals.
More Patients Report Life-Altering Injuries
Additional patients have come forward describing catastrophic injuries after SCS implantation. One patient reports being virtually paralyzed, while another suffers from debilitating pain that prevents daily functioning. Thousands of similar claims nationwide allege that manufacturers and regulators overstated benefits while minimizing risks.
Spinal Stimulator Settlement Amounts
When people ask about spinal stimulator settlement amounts, they are usually not asking out of curiosity. They are trying to understand whether the harm they suffered is being taken seriously and whether the legal system recognizes the scope of what went wrong. The truth is that spinal cord stimulator lawsuits are not really about chasing a number. They are intended to compensate for a cascade of losses that often follow implantation when these devices fail.
For many patients, the first injury is not the worst one. What follows can be months or years of repeat surgeries, hospitalizations, imaging studies, and failed attempts to fix a device that was supposed to reduce pain, not multiply it. Each revision surgery carries its own risks, costs, and recovery time. For some, the device never works as promised again. For others, it must be removed entirely, leaving them with permanent damage and no pain relief at all.
There is also a less visible cost that shows up in almost every serious case: loss of trust in the medical system. Patients often describe feeling dismissed when they report shocks, burning sensations, or worsening pain. They are told the symptoms are rare, expected, or unrelated, even as their quality of life steadily declines. That erosion of trust, combined with physical suffering and financial strain, is a core driver of these lawsuits.
Only after those realities are understood does it make sense to talk about settlement compensation and payouts. Higher spinal stimulator settlement amounts tend to be associated with cases involving clear, documented harm rather than temporary discomfort. The strongest cases often include multiple revision surgeries, complete explantation of the device, or injuries that permanently alter neurological function.
Predicting spinal stimulator settlement amounts at this stage of the game is pure folly. But victims want to know what their lawyers think about what the value of their case could be if all goes perfectly as hoped and planned. The chart below is a speculative framework that uses specific values to show how compensation and payouts can scale with injury severity.
- Number of surgeries, including revision and explantation
- Objective proof of migration, lead failure, overheating, or malfunction
- Neurologic injury or bowel or autonomic dysfunction
- Medical expenses, wage loss, and diminished earning capacity
- Permanency, credibility, and the jurisdiction where the case is filed
Are Quick Settlements Possible?
You do not want to bet on a quick settlement. But it does happen. A lawsuit filed in October alleged that a woman suffered severe and worsening injuries after receiving a spinal cord stimulator manufactured by Boston Scientific, claiming the device migrated, delivered painful electrical shocks, and failed to perform as promised. The complaint accused the company of selling a defective medical device and failing to warn patients and doctors about known risks, while also raising broader concerns about regulatory oversight.
The plaintiff alleged that the stimulator differed materially from the version originally approved by the FDA and that those changes increased the risk of harm without adequate testing or disclosure. The case fit into a growing wave of spinal cord stimulator litigation focusing less on surgical error and more on device design, post-approval modifications, and inadequate warnings.
This one was quick. The lawsuit was resolved with Boston Scientific reaching a settlement in December, less than 60 days after the suit was filed and before any meaningful pretrial discovery. shortly after the complaint was filed. The timing of the settlement is interesting because we are still getting a feel for how these cases will be defended and if many can settle without even filing a lawsuit.
Bringing a Spinal Cord Stimulator Lawsuit
If you or a loved one experienced complications after spinal cord stimulator implantation, including electrocution, burns, infections, neurological injury, or repeated surgeries, you may have legal options. Lawsuits seek compensation for medical costs, lost income, pain and suffering, and long-term disability, while holding manufacturers accountable for unsafe products and inadequate warnings.
Eligibility for Spinal Cord Stimulator Lawsuit
Patients who received a spinal cord stimulator expecting relief, but instead experienced serious complications, may have grounds to pursue a legal claim. The cases lawyers like us are looking for involve more than just a bad outcome or an unfortunate side effect. They raise broader questions about how these devices were designed, tested, marketed, and regulated in the first place.
You may qualify if you or a loved one had a spinal cord stimulator implanted and later suffered injuries such as infection, shocks, burns, device migration, neurological damage, bowel, or autonomic complications. You have the most viable claims. The upper-tier cases for settlement would involve victims who need repeated revision surgeries or complete device removal. In many cases, patients report they were never clearly warned that these risks were possible, let alone likely.
Eligibility does not depend on whether the device is still implanted, whether symptoms appeared immediately, or whether the manufacturer labeled the complication as “rare.” What matters is whether the device failed to perform as promised—or introduced dangers that were not adequately disclosed. Lawsuits often focus on whether manufacturers minimized known risks, overstated benefits, or continued selling devices that had changed in meaningful ways without proper safety review.
Families may also have claims in cases involving severe disability or death following implantation, particularly where complications cascaded rapidly and left little opportunity for intervention. These cases are not just about individual harm, but about accountability within a system that often favors speed, scale, and market share over long-term patient safety.
If you believe your injury was dismissed, normalized, or treated as an acceptable tradeoff, you are not alone. Many of the claims now moving through courts nationwide began the same way, with patients realizing too late that the full story was never told.
Contact Us About Spinal Cord Stimulator Lawsuits
Our firm is seeking spinal cord stimulator lawsuits nationwide. If you have suffered physical or mental harm as a result of a spinal cord stimulator, contact us today for a free case evaluation. Call us at 800-553-8082 or contact us online.